BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30

$85.60+0.56 (+0.66%)

Close on Nov 13, 2026Market cap $21.50BP/E –Yield –

BioNTech statistics

71 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: Jun 2, 2022
Fundamentals through: Dec 31, 2025
Share price as of: –

Valuation ratiosIndustry

Market Cap: €19.28B; €768.08M
Enterprise Value: €11.60B; €535.62M
PS Ratio: 6.72; 7.25
P/FCF Ratio: 68.63; –
P/OCF Ratio: 42.28; –

Enterprise valuationIndustry

EV / Sales: 4.04; 4.04
EV / FCF: 41.31; –

Share statisticsIndustry

Shares Outstanding: 251M; 100M
Shares Change (YoY): 0.54%; 5.61%
Float: 105M; 79M
Shares Held by Insiders: 58.2%; 9.05%
Shares Held by Institutions: 18.9%; 20.8%

Short sellingIndustry

Short Interest: 2M; –
Short Interest Change: -1.17%; -2.55%
Days to Cover: 2.15; 3.54

Stock price statisticsIndustry

Price Change (1 Week): -2.18%; 0.08%
Price Change (1 Month): -5.10%; -2.76%
Price Change (3 Months): -6.55%; -21.7%
Price Change (6 Months): -4.41%; -11.3%
Price Change (YTD): -10.1%; -15.5%
Price Change (1 Year): -23.4%; -17.6%
Price Change (3 Years): -15.0%; -8.10%
Price Change (5 Years): -64.1%; -54.7%
Average Volume (10 Days): 955,714; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 1M; –
Relative Volume: 0.74; 0.63
Relative Strength Index (14): 40.4; 48.4
Volatility (1 Year): 47.1%; 65.2%
Beta (5 Years): 0.82; 0.86

MarginsIndustry

Gross Margin: 77.6%; 42.5%
Operating Margin: -49.0%; -33.2%
Pretax Margin: -36.6%; -36.6%
Profit Margin: -39.6%; 5.34%
EBITDA Margin: -35.6%; -28.6%
FCF Margin: 9.79%; -24.4%

Returns on capitalIndustry

Return on Assets (ROA): -5.10%; -1.57%
Return on Capital Employed (ROCE): -7.08%; -23.8%

Financial positionIndustry

Current Ratio: 7.54; 3.49
Quick Ratio: 4.01; 1.51
Interest Coverage: -20.13; -0.71

GrowthIndustry

Revenue Growth (YoY): 4.32%; -1.08%
Revenue Growth (3Y CAGR): -45.1%; 1.61%
Revenue Growth (5Y CAGR): 42.9%; 14.0%

EfficiencyIndustry

Asset Turnover: 0.13; 0.31
Inventory Turnover: 3.26; 1.36
Revenue Per Employee: €5.74M; €855.98K
Profits Per Employee: -€2.27M; -€43.26K
Employee Count: 500; 304
WACC: 9.18%; 9.49%

Income statement (TTM)Industry

Revenue: €2.87B; €465.66M
Gross Profit: €2.23B; €1.08B
Operating Income: -€1.40B; -€54.01M
Pretax Income: -€1.05B; -€47.40M
Net Income: -€1.14B; €157.18M
EBITDA: -€1.02B; -€42.85M
EPS (Diluted): -4.70 EUR; -0.55 EUR

Balance sheetIndustry

Cash & Short-Term Investments: €7.68B; €199.29M
Net Cash (Debt): €7.68B; €111.50M
Net Cash Per Share: 30.55 EUR; 1.53 EUR
Working Capital: €14.00B; €119.55M

Cash flow (TTM)Industry

Operating Cash Flow: €456.00M; -€42.16M
Capital Expenditures: -€175.10M; -€2.34M
Free Cash Flow: €280.90M; -€52.90M
FCF Per Share: 1.12 EUR; -0.48 EUR

Dividends and yieldsIndustry

Earnings Yield: -5.89%; -1.80%
FCF Yield: 1.46%; -13.3%

Taxes and interestIndustry

Interest Expense: €69.80M; €55.20M
Income Tax: €85.30M; €80.00K

Scores and fair valueIndustry

Altman Z-Score: 6.01; 1.23
Piotroski F-Score: 5; 5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	BNTX	S&P 500	Difference	BNTX per year	S&P 500 per year
1 month	-3.8%	-3.0%	−0.8 pts
3 months	-7.1%	-2.8%	−4.3 pts
Year to date	-10.1%	+11.5%	−21.6 pts
1 year	-17.6%	+13.5%	−31.1 pts
3 years	-12.6%	+77.7%	−90.3 pts	-4.4%	+21.1%
5 years	-63.6%	+72.6%	−136.2 pts	-18.3%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M BNTX shares were sold short on Oct 30, 2026, down 1.2% from the previous report. At recent volumes it would take 2.1 days to buy them back. Over the last 20 sessions, 29.5% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	2,245,589	-1.2%	1,042,712	2.1
Oct 15, 2026	2,272,174	-9.0%	1,105,391	2.1
Sep 30, 2026	2,496,813	+7.5%	799,043	3.1
Sep 15, 2026	2,322,764	+0.9%	895,258	2.6
Aug 31, 2026	2,302,864	-8.2%	2,348,403	1.0
Aug 14, 2026	2,507,433	+1.7%	1,077,030	2.3
Jul 31, 2026	2,465,659	+8.6%	750,960	3.3
Jul 15, 2026	2,271,284	-2.3%	780,258	2.9
Jun 30, 2026	2,324,296	-15.2%	834,892	2.8
Jun 15, 2026	2,740,601	+21.5%	1,171,849	2.3
May 29, 2026	2,255,806	-8.0%	948,516	2.4
May 15, 2026	2,452,684	+10.7%	942,883	2.6